150 related articles for article (PubMed ID: 3290703)
1. Creutzfeldt-Jakob disease following pituitary-derived human growth hormone therapy: a new American case.
Marzewski DJ; Towfighi J; Harrington MG; Merril CR; Brown P
Neurology; 1988 Jul; 38(7):1131-3. PubMed ID: 3290703
[TBL] [Abstract][Full Text] [Related]
2. A new case of Creutzfeldt-Jakob disease associated with human growth hormone therapy in New Zealand.
Croxson M; Brown P; Synek B; Harrington MG; Frith R; Clover G; Wilson J; Gajdusek DC
Neurology; 1988 Jul; 38(7):1128-30. PubMed ID: 3290702
[TBL] [Abstract][Full Text] [Related]
3. Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications.
Tintner R; Brown P; Hedley-Whyte ET; Rappaport EB; Piccardo CP; Gajdusek DC
Neurology; 1986 Jul; 36(7):932-6. PubMed ID: 3520381
[TBL] [Abstract][Full Text] [Related]
4. Abnormal proteins in the cerebrospinal fluid of a patient with Creutzfeldt-Jakob disease following administration of human pituitary growth hormone.
Macário ME; Moura-Neto V; Vaisman M; Araujo HM; Buescu A; Cordeiro JG; Chagas C
Braz J Med Biol Res; 1992; 25(11):1127-30. PubMed ID: 1342593
[TBL] [Abstract][Full Text] [Related]
5. The decline and fall of Creutzfeldt-Jakob disease associated with human growth hormone therapy.
Brown P
Neurology; 1988 Jul; 38(7):1135-7. PubMed ID: 3290705
[No Abstract] [Full Text] [Related]
6. Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient.
New MI; Brown P; Temeck JW; Owens C; Hedley-Whyte ET; Richardson EP
Neurology; 1988 Jul; 38(7):1133-4. PubMed ID: 3290704
[TBL] [Abstract][Full Text] [Related]
7. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States.
Fradkin JE; Schonberger LB; Mills JL; Gunn WJ; Piper JM; Wysowski DK; Thomson R; Durako S; Brown P
JAMA; 1991 Feb; 265(7):880-4. PubMed ID: 1992185
[TBL] [Abstract][Full Text] [Related]
8. Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study.
Billette de Villemeur T; Gelot A; Deslys JP; Dormont D; Duyckaerts C; Jardin L; Denni J; Robain O
Neuropathol Appl Neurobiol; 1994 Apr; 20(2):111-7. PubMed ID: 8072642
[TBL] [Abstract][Full Text] [Related]
9. [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].
Roos RA; Wintzen AR; Will RG; Ironside JW; van Duinen SG
Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1190-3. PubMed ID: 8692356
[TBL] [Abstract][Full Text] [Related]
10. Iatrogenic Creutzfeldt-Jakob disease following human growth hormone therapy: case report.
Caboclo LO; Huang N; Lepski GA; Livramento JA; Buchpiguel CA; Porto CS; Nitrini R
Arq Neuropsiquiatr; 2002 Jun; 60(2-B):458-61. PubMed ID: 12131950
[TBL] [Abstract][Full Text] [Related]
11. Creutzfeldt-Jakob disease after administration of human growth hormone.
Powell-Jackson J; Weller RO; Kennedy P; Preece MA; Whitcombe EM; Newsom-Davis J
Lancet; 1985 Aug; 2(8449):244-6. PubMed ID: 2862420
[TBL] [Abstract][Full Text] [Related]
12. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
[TBL] [Abstract][Full Text] [Related]
13. Pituitary growth hormone and Creutzfeldt-Jakob disease.
Norrby E
Acta Paediatr Scand Suppl; 1986; 325():116-24. PubMed ID: 3296633
[No Abstract] [Full Text] [Related]
14. Human growth hormone and Creutzfeldt-Jakob disease.
Zekauskas S; Boggs MB; Wilson DP
J Okla State Med Assoc; 1990 Sep; 83(9):447-8. PubMed ID: 2280278
[TBL] [Abstract][Full Text] [Related]
15. Creutzfeldt-Jakob disease 38 years after diagnostic use of human growth hormone.
Croes EA; Roks G; Jansen GH; Nijssen PC; van Duijn CM
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):792-3. PubMed ID: 12023427
[TBL] [Abstract][Full Text] [Related]
16. Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.
Buchanan CR; Preece MA; Milner RD
BMJ; 1991 Apr; 302(6780):824-8. PubMed ID: 2025705
[TBL] [Abstract][Full Text] [Related]
17. Creutzfeldt-Jakob disease after pituitary-derived human growth hormone therapy: two cases with valine 129 homozygous genotype.
Masson C; Delalande I; Deslys JP; Hénin D; Fallet-Bianco C; Dormont D; Leys D
Neurology; 1994 Jan; 44(1):179-80. PubMed ID: 7904734
[No Abstract] [Full Text] [Related]
18. The clinical neurology and epidemiology of Creutzfeldt-Jakob disease, with special reference to iatrogenic cases.
Brown P
Ciba Found Symp; 1988; 135():3-23. PubMed ID: 3044708
[TBL] [Abstract][Full Text] [Related]
19. [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
Billette de Villemeur T; Gourmelen M; Beauvais P; Rodriguez D; Vaudour G; Deslys JP; Dormont D; Richard P; Richardet JM
Rev Neurol (Paris); 1992; 148(5):328-34. PubMed ID: 1448646
[TBL] [Abstract][Full Text] [Related]
20. A further British case of growth hormone induced Creutzfeldt-Jakob disease.
Ellis CJ; Katifi H; Weller RO
J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1200-2. PubMed ID: 1479400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
